CannTrust, a leading cannabis drug provider, is blocking sales amid the Health Canada probe


CannTrust, which calls itself a "leading" medical cannabis supplier, voluntarily discontinued all sales and shipments of its product after Health Canada discovered that it was growing cannabis in five unlicensed rooms and that the ministry received inaccurate information .

The company has also set up a special committee to investigate the matter.

CannTrust is doing it as a "precaution" while Health Canada investigates the company structure in Vaughan, Ontario, a release of the company he said Thursday.

WATCH: January 9 – CannTrust is a marijuana producer on the lack of pots, legalization of cannabis and product innovation

"CannTrust is working closely with the regulator through the review process and plans to provide further details on the duration of storage and other developments as they become available," the statement added.

The moves come after the company said it had imposed over 5,000 kg of dried cannabis that had been grown in unlicensed rooms at a Pelham, Ontario facility. between October 2018 and March 2019.

At the time the company had questions for pending rooms with Health Canada.

READ MORE: 5,000 kg of Cannabust cannabis are on hold after Health Canada has discovered unlicensed growth

On Monday, CannTrust announced that it had suspended approximately 7,500 kg of dried cannabis equivalent at its Vaughan plant.

The product had been produced in rooms without Pelham's license, CannTrust said.

On Wednesday the Ontario Cannabis Store announced that it had withdrawn some of the company's products from online sales and that it had been shipped to physical stores, as investigated by Health Canada.

WATCH: October 16, 2018 – Canadian cannabis companies are betting that the world will want our grass

Customers who had ordered the CannTrust product could be reimbursed if the products were returned unopened within two weeks of delivery.

The Ontario Cannabis Store did not say which products were pulled.

CannTrust serves over 72,000 medical patients with dry products, extracts and capsules, he said in the release.

The company operates a collection facility in Pelham and a manufacturing facility in Vaughan.

  • With file of The Canadian Press

© 2019 Global News, a division of Corus Entertainment Inc.

. (tagToTranslate) CannTrust (t) cannabis cannabis (t) cannabis cannabis sales (t) cannabust cannabis suspended sales (t) CannTrust Health Canada (t) canntrust health canada probe (t) canntrust sales (t) canntrust sales halted (t) le canntrust sales have stopped health canada probe (t) sales of suspended canntrust (t) medical cannabis (t) News


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.